Dengue virus
| Anisomycin | DENV-1 | DNA synthesis inhibitor | Preclinical | — | Human ribosome | |
| Azauridine | DENV-1 | Nucleoside analog | Preclinical | — | Viral RNA pol | |
| Betulinic Acid | DENV-1 | Unknown | Preclinical | — | Unknown | |
| Fenretinide | DENV-1 | Unclear | Preclinical | — | Human RAR | |
| Glycyrrhizin | DENV-1 | 0 | Preclinical | — | Human TNF | |
| Minocycline | DENV-1 | Inhibition of autophagy | Preclinical | — | Human MIF | |
| Posaconazole | DENV-1 | Inhibition of OSBP and ORP4; Inhibition of viral organelle formation | Preclinical | — | Human lipid transfer protein | |
| Ribavirin | DENV-1 | Nucleoside inhibitor; Guanosine (ribonucleic) analog | Approved (other) | Japan | Viral RNA pol | |
| Sunitinib | DENV-1 | Broad TK inhibitor | Preclinical | — | Human PTK |